Shahram Salek-Ardakani
2021
In 2021, Shahram Salek-Ardakani earned a total compensation of $4M as Chief Scientific Officer at Janux Therapeutics.
Compensation breakdown
Bonus | $125,000 |
---|---|
Non-Equity Incentive Plan | $56,818 |
Option Awards | $3,638,223 |
Salary | $189,394 |
Total | $4,009,435 |
Salek-Ardakani received $3.6M in option awards, accounting for 91% of the total pay in 2021.
Salek-Ardakani also received $125K in bonus, $56.8K in non-equity incentive plan and $189.4K in salary.
Rankings
In 2021, Shahram Salek-Ardakani's compensation ranked 3,342nd out of 12,406 executives tracked by ExecPay. In other words, Salek-Ardakani earned more than 73.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,342 | 73rd |
Manufacturing | 1,357 | 75th |
Chemicals And Allied Products | 552 | 77th |
Drugs | 491 | 77th |
Pharmaceutical Preparations | 339 | 78th |
Salek-Ardakani's colleagues
We found two more compensation records of executives who worked with Shahram Salek-Ardakani at Janux Therapeutics in 2021.